Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Duarte, CA
NPI: 1225046147Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get MD Anthony's Phone Numberphone_androidMobile
Get MD Anthony's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1984 - 2026
PA State Medical License
1983 - 1990

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
City of Hope National Medical Center
Fellowship • Hematology and Medical Oncology
1985 - 1987
UPMC Medical Education
Residency • Internal Medicine
1982 - 1984
University of Cape Town Faculty of Medicine
Medical School
Until 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 76 | 353 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 34 | 224 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 18 | 26 |
| 4 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 13 | 33 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 11 | 28 |
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML.
Authors: Aaron Goldberg, Jorge Ramos Perez, Robert Lindsley, Richard Stone, Brian Ball, Jan Philipp Bewersdorf, Shai Shimony, Guido Marcucci, Amer Zeidan, Eytan Stein, Daniel Deangelo, Rebecca Bystrom, Evan Chen, Vinod Pullarkat
Publication Date: 2024-09
Authors: Ryotaro Nakamura, Stephen Forman, Guido Marcucci, Amandeep Salhotra, Vinod Pullarkat
Journal: Bone Marrow Transplant
Publication Date: 2019-05-14
Lead Sponsor: Stemline Therapeutics, Inc.
Intervention / Treatment: DRUG: Tagraxofusp-erzs
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Venetoclax, DRUG: Decitabine, BIOLOGICAL: Navitoclax
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: SGN-CD33A, DRUG: Daunorubicin, DRUG: Standard dose cytarabine for induction, DRUG: High dose cytarabine for consolidation